Predict your next investment

HEALTHCARE

See what CB Insights has to offer

Founded Year

1982

Stage

IPO | IPO

Total Raised

$19.05M

Date of IPO

12/28/1993

About Interpore International

Synthetic bone graft material for the orthopaedic, oral, and maxillofacial markets. The company's synthetic bone graft products are derived from coral using its proprietary manufacturing process, which converts the unique skeletal structures of certain species of coral to coralline hydroxyapatite, a biocompatible material. Coralline hydroxyapatite has interconnected porosity, architecture and chemical composition similar to that of human cancellous bone, and facilitates bone and tissue ingrowth. The company also distributes a titanium dental implant system for the rehabilitation of partially and totally toothless patients. In November 1992, the company received FDA approval to market its synthetic bone graft material Pro Osteon Implant 500 Coralline Hydroxyapatite Bone Void Filler for the repair of acute metaphyseal defects in conjunction with rigid internal fixation as dictated by the clinical use requirements in skeletally mature individuals when there is no autogenous bone donor site available.

Interpore International Headquarter Location

181 Technology Drive

Irvine, California, 92618,

United States

(714)453-3200

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Interpore International

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Interpore International is included in 1 Expert Collection, including Regenerative Medicine.

R

Regenerative Medicine

1,755 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.